NIH study identifies experimental opioid with strong pain relief and lower addiction risk

The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century but largely abandoned due to their high potency. This research revisits nitazenes using modern pharmacological tools and aims to redesign them for greater safety. Investigators say the results represent unexpected...Read Entire Article

Apr 10, 2026 - 02:44
 0
NIH study identifies experimental opioid with strong pain relief and lower addiction risk
The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century but largely abandoned due to their high potency. This research revisits nitazenes using modern pharmacological tools and aims to redesign them for greater safety. Investigators say the results represent unexpected...

Read Entire Article

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

XINKER - Business and Income Tips Explore XINKER, the ultimate platform for mastering business strategies, discovering passive income opportunities, and learning success principles. Join a community of thinkers dedicated to achieving financial freedom and entrepreneurial excellence.